查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1770815

一次性生物反應器市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、類型、細胞類型、分子、應用、用途、最終用戶、地區和競爭細分，2020-2030 年

Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Type of Cell, By Molecule, By Application, By Usage, By End User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年，全球一次性生物反應器 (SUB) 市場規模為23億美元，預計到2030年將達到47.5億美元，預測期內複合年成長率為12.85%。市場成長的動力源自於研發活動的增加、合作的拓展以及對新型疫苗和療法日益成長的需求。慢性病和傳染病的發生率上升，以及單株抗體的不斷發展，進一步推動了市場擴張。 SUB提供了一種可擴展且經濟高效的傳統不銹鋼系統替代方案，使其在臨床和商業生產中都具有吸引力。

市場概覽
預測期 2026-2030
2024年市場規模 23億美元
2030年市場規模 47.5億美元
2025-2030 年複合年成長率 12.85%
成長最快的領域 基因改造細胞
最大的市場 北美洲

例如，2022年1月，HaemaLogiX Ltd與Lonza合作生產了一批臨床批次的KappaMab，這是一種針對κ骨髓瘤抗原的單株抗體，證明了SUB在高階藥物開發中的作用。此外，生物製劑的快速普及、政府對生物製劑研究的資助以及對個人化醫療的日益關注，正在推動全球製藥和生物製藥行業對SUB的需求。 SUB的優勢包括降低污染風險、縮短週轉時間以及降低清潔要求，使其在現代生物製程操作中日益不可或缺。

關鍵市場促進因素

生物製藥需求和生物相似藥生產激增

主要市場趨勢

數位科技在生物加工中的整合

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球一次性生物反應器市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品（一次性生物反應器系統、一次性培養基袋、一次性過濾組件、其他產品）
    • 依類型（攪拌槽式SUB、波浪誘導式SUB、鼓泡塔式SUB、其他SUB）
    • 依細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單株抗體、疫苗、基因改造細胞、幹細胞、其他分子）
    • 按應用（研發、生物生產）
    • 依用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按地區（北美、歐洲、亞太、南美、中東和非洲）
    • 按公司分類（2024）
  • 市場地圖
  • 按產品
  • 按類型
  • 按細胞類型
  • 按分子
  • 按應用
  • 按用途
  • 按最終用戶
  • 按地區

第6章：北美一次性生物反應器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲一次性生物反應器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太一次性生物反應器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲一次性生物反應器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲一次性生物反應器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 實驗室自動化活動的需求不斷成長
  • 生物庫擴大採用實驗室資訊學
  • 越來越多引入技術先進的軟體服務
  • 挑戰
  • 缺乏實驗室資訊學整合標準
  • 嚴格的規定

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球一次性生物反應器市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • ABEC, INC.
  • Able Corporation & Biott Corporation.
  • BBI-Biotech Gmbh.
  • Cellexus Biosystems PLC.
  • Celltainer Biotech BV.
  • Danaher Corporation
  • Distek Inc.
  • Eppendorf AG.
  • G&G Technologies, Inc.
  • Getinge AB

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15169

The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market's growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.30 Billion
Market Size 2030USD 4.75 Billion
CAGR 2025-203012.85%
Fastest Growing SegmentGene Modified Cells
Largest MarketNorth America

For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen-demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.

Key Market Drivers

Surge in Biopharmaceutical Demand and Biosimilar Production

The growing demand for biopharmaceutical products-particularly monoclonal antibodies, vaccines, and biosimilars-is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.

Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.

Key Market Trends

Integration of Digital Technologies in Bioprocessing

The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control-enhancing efficiency, product quality, and compliance.

Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.

Key Market Players

  • ABEC, INC.
  • Able Corporation & Biott Corporation
  • BBI-Biotech GmbH
  • Cellexus Biosystems PLC
  • Celltainer Biotech BV
  • Danaher Corporation
  • Distek Inc.
  • Eppendorf AG
  • G&G Technologies, Inc.
  • Getinge AB

Report Scope:

In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single-Use Bioreactors Market, By Product:

  • Single use bioreactor systems
  • Single use media bags
  • Single use filtration assemblies
  • Other products

Single-Use Bioreactors Market, By Type:

  • Stirred tank SUB
  • Wave induced SUB
  • Bubble Column SUB
  • Other SUB

Single-Use Bioreactors Market, By Type of Cell:

  • Mammalian Cell
  • Bacterial Cell
  • Yeast Cell
  • Other Cells

Single-Use Bioreactors Market, By Molecule:

  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other molecules

Single-Use Bioreactors Market, By Application:

  • Research and Development
  • Bioproduction

Single-Use Bioreactors Market, By Usage:

  • Lab scale production
  • Pilot scale production
  • Large scale production

Single-Use Bioreactors Market, By End User:

  • Pharmaceutical and Biopharmaceutical companies
  • CROSs & CMOS
  • Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 5.2.5. By Application (Research and Development, Bioproduction)
    • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.9. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Product
  • 5.3.2 By Type
  • 5.3.3 By Type of Cell
  • 5.3.4 By Molecule
  • 5.3.5 By Application
  • 5.3.6 By Usage
  • 5.3.7 By End User
  • 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 6.2.5. By Application (Research and Development, Bioproduction)
    • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 6.2.8. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Single-Use Bioreactors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Type of Cell
        • 6.3.1.2.4. By Molecule
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By Usage
        • 6.3.1.2.7. By End User
    • 6.3.2. Canada Single-Use Bioreactors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Type of Cell
        • 6.3.2.2.4. By Molecule
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By Usage
        • 6.3.2.2.7. By End User
    • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Type of Cell
        • 6.3.3.2.4. By Molecule
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By Usage
        • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 7.2.5. By Application (Research and Development, Bioproduction)
    • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 7.2.8. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Single-Use Bioreactors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Type of Cell
        • 7.3.1.2.4. By Molecule
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By Usage
        • 7.3.1.2.7. By End User
    • 7.3.2. Germany Single-Use Bioreactors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Type of Cell
        • 7.3.2.2.4. By Molecule
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By Usage
        • 7.3.2.2.7. By End User
    • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Type of Cell
        • 7.3.3.2.4. By Molecule
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By Usage
        • 7.3.3.2.7. By End User
    • 7.3.4. Italy Single-Use Bioreactors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Type of Cell
        • 7.3.4.2.4. By Molecule
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By Usage
        • 7.3.4.2.7. By End User
    • 7.3.5. Spain Single-Use Bioreactors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Type of Cell
        • 7.3.5.2.4. By Molecule
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By Usage
        • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 8.2.5. By Application (Research and Development, Bioproduction)
    • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 8.2.8. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Single-Use Bioreactors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Type of Cell
        • 8.3.1.2.4. By Molecule
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By Usage
        • 8.3.1.2.7. By End User
    • 8.3.2. India Single-Use Bioreactors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Type of Cell
        • 8.3.2.2.4. By Molecule
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By Usage
        • 8.3.2.2.7. By End User
    • 8.3.3. Japan Single-Use Bioreactors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Type of Cell
        • 8.3.3.2.4. By Molecule
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By Usage
        • 8.3.3.2.7. By End User
    • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Type of Cell
        • 8.3.4.2.4. By Molecule
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By Usage
        • 8.3.4.2.7. By End User
    • 8.3.5. Australia Single-Use Bioreactors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Type of Cell
        • 8.3.5.2.4. By Molecule
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By Usage
        • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 9.2.5. By Application (Research and Development, Bioproduction)
    • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 9.2.8. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Type of Cell
        • 9.3.1.2.4. By Molecule
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By Usage
        • 9.3.1.2.7. By End User
    • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Type of Cell
        • 9.3.2.2.4. By Molecule
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By Usage
        • 9.3.2.2.7. By End User
    • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Type of Cell
        • 9.3.3.2.4. By Molecule
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By Usage
        • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 10.2.5. By Application (Research and Development, Bioproduction)
    • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 10.2.8. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Type of Cell
        • 10.3.1.2.4. By Molecule
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By Usage
        • 10.3.1.2.7. By End User
    • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Type of Cell
        • 10.3.2.2.4. By Molecule
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By Usage
        • 10.3.2.2.7. By End User
    • 10.3.3. UAE Single-Use Bioreactors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Type of Cell
        • 10.3.3.2.4. By Molecule
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By Usage
        • 10.3.3.2.7. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.1.1 Growing demand for lab automation activities
  • 11.1.2 Growing adoption of lab informatics by biobanks
  • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
  • 11.2.1 Lack of integration standards for laboratory informatics
  • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ABEC, INC.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Able Corporation & Biott Corporation.
  • 15.3. BBI-Biotech Gmbh.
  • 15.4. Cellexus Biosystems PLC.
  • 15.5. Celltainer Biotech BV.
  • 15.6. Danaher Corporation
  • 15.7. Distek Inc.
  • 15.8. Eppendorf AG.
  • 15.9. G&G Technologies, Inc.
  • 15.10. Getinge AB

16. Strategic Recommendations

17. About Us & Disclaimer